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Abstract
Background: Reconstruction of the defects after surgical resection of tumors is one of the
important issues in surgical oncology. It is essential that the defect should be covered with a tissue
quite similar to the original one and is best achieved by harvesting tissue from an area adjacent to
the defect. Tissue expansion is one of the most frequently used reconstructive techniques. A
number of studies evaluated blood circulation, capsule formation, tissue tolerance,
histomorphological changes and complications of expander placement. However, only a few
attempted to enhance tissue expansion. This study we aimed to evaluate verapamil, a calcium
channel blocker, to enhance tissue expansion.
Material and method: Twelve New Zealand rabbits weighing between 900 gm and 1200 gm
were assigned into study and control groups. High volume expanders (100, 200 or 300 cc) were
placed into the subcutaneous tissue. Rabbits in the study group received verapamil. Expanders in
the control group were inflated every three days to achieve same pressure as the study group. The
size of the flaps was assessed by applying pressure on tip of the flap to demonstrate the contraction.
Histopathological examinations were performed.
Results: By administering liquid earlier and more quickly less flap retraction was observed in the
study group. In the control group expanders were exposed in two rabbits while no complication
occurred in the study group. Following extraction of the expanders, the flaps were elevated and
less retraction was observed in the study group compared to controls.
Conclusion: Verapamil is safe when used topically and provides less retracted flaps. It can be
suggested that verapamil acts on the myofibroblasts in the capsule around tissue expanders and
thus increases efficiency of the expanders.
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Introduction
Covering of the defect after surgical resection of the pri-
mary or metastatic neoplasm is essential and the best tis-
sue for such coverage is the one, which is similar to the
original resected tissue. This is best achieved by harvesting
a tissue from an area adjacent to the defect. However, har-
vesting a large local flap from an adjacent tissue will lead
to formation of an additional defect at times. In addition,
the adjacent area may not provide an appropriate size tis-
sue. The use of tissue expanders may allow an original-like
tissue for coverage. Tissue expansion is a mechanical pro-
cedure, which expands the surface of an available local
area [1]. All living tissues respond to mechanical strength
and the mitosis in these tissues increases as the tissues
gradually expand. Clinical application of tissue expanders
is widespread and the expanders are indispensable for
reconstruction of large defects resulting from surgical
treatment of tumors, many congenital anomalies and
acquired defects. Expanders are most frequently used in
reconstruction of breast and scalp defects [2,3]. Schmidt et
al, summarized the advantages of expanders as: a) best tis-
sue match with defect areas, b) lack of a wound at the
donor site, and c) maintenance of vascular supply [4]. It
has been demonstrated that a fibrous capsule was formed
around tissue expanders and examination of this capsule
and the surrounding dermis on electron microscopy has
shown an increase in the number of contractile fibroblasts
[5]. These fibroblasts contain actin and myosin, which
account for not only wound healing but also for forma-
tion of a fibrous capsule around the expanders [6]. Vera-
pamil, a safe and widely used calcium chennal blocker,
was used in the present study as it has a topical effect on
the collagen tissue fibroblasts with an aim to determine
whether it can decrease pressure around the expanders
and thus increasing efficiency of tissue expanders.
Material and method
The study was performed in Experimental Laboratory of
Plastic and Reconstructive Surgery Clinic in Izmir Atatürk
Teaching Hospital, Turkey, using twelve New Zealand rab-
bits weighing between 900 gm and 1200 gm. There were
six rabbits in verapamil group and six rabbits in control
group. Within each group, 100, 200 and 300 cc expanders
were used in two animals each. Approval was obtained
from the ethical committee of the hospital and the ani-
mals were kept in separate cages in temperature, light and
airflow-regulated rooms. Experiments were conducted
under aseptic conditions. The rabbits were anesthetized
with 1 ml ketamine hydrochloride 50 mg/ml and 1 ml of
2% xylazine hydrochloride.
High volume rectangular expanders (McGhan®, Medical
Corporation, USA) were used. The rabbits were assigned
into a study group to receive verapamil and into a control
group and each group was divided into three subgroups
based on the volume of the expanders; Group I: 100 cc,
Group II: 200 cc and Group III: 300 cc. A reservoir was
connected to each expander with a 3 cm silicon tube.
Apparatus for administration of verapamil
Verapamil was administrated using a special cannula:
Thirty holes were drilled on an 2 mm diameter 30 cm long
intravenous catheter and one end of the catheter was
blocked (Figure 1). Thus, the drug was spilled only
through the holes and spreads on the base where the
expanders were placed. The cannula was twisted to form a
spiral and sutured with 5/0 silk. This apparatus was steri-
lized in a gas autoclave.
The back of the rabbits were shaved and cleaned with pov-
idon iodide and a 3 cm horizontal incision was made 5
cm away from the tail. After dividing the cutaneous and
subcutaneous tissue a diverticulum was created on the
panniculus carnosus. At this level, a dissection of the same
Apparatus for administration of verapamil Figure 1
Apparatus for administration of verapamilWorld Journal of Surgical Oncology 2003, 1 http://www.wjso.com/content/1/1/19
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size as the base of the expander was made followed by
placement of the cannula and the expander into the diver-
ticulum (Figure 2). The reservoir of the expander was
placed 2 cm away from the expander in a postero-lateral
position. One end of the cannula was left outside the tis-
sue and the skin was sutured with 3/0 prolene. Penicillin
was administered once to all animals for prophylaxis.
Measurement of expansion
After the expanders were placed, four spots of crystal violet
were created with a caliper on two separate planes on the
shaved skin of the rabbits (Figure 3). The length and
width of the expanders were labeled as AB and XY respec-
tively. Following each expansion, the distances between
the spots was measured.
Administration of verapamil
Immediately after the expanders were placed and every
three days thereafter, 2.5 ml verapamil hydrochloride (5
mg/2ml Isoptin®, Knoll Inc.) mixed with 1 cc NaCl was
administered in the study group, and only 1 cc NaCl was
given in the control group.
Expansion of expanders and measurement of intra-
expander pressure
The expanders were not inflated immediately after they
were placed, but inflation was started three days later with
15–20% inflation every three days and all expansions
took place at the same time postoperatively. At each
expansion, first intra-expander pressure was measured in
the control group and then the expanders in the verapamil
group were inflated with saline equal to this pressure.
When the expansions were completed, pressure in each
Photograph showing application of the apparatus Figure 2
Photograph showing application of the apparatus
Photograph showing AB and XY points of the tissue expan- sion in rabbit Figure 3
Photograph showing AB and XY points of the tissue expan-
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expander, amount of expansion and changes in the flaps
were recorded.
Determination of retraction ratios in flaps
The length of the flaps was measured twice to determine
retraction ratios. The first measurement was made after
the procedure of expansion was completed and the sec-
ond measurement was made after the flaps were elevated.
Following the elevation of the flaps, using a system of pul-
leys, a force of 2.46 Newton was applied on the tips of the
flaps and the length of the flaps under the pressure was
measured (Figure 4). Thus, the difference between the two
values provided retraction ratios.
Evaluation
The differences between AB and XY lengths obtained after
the completion of the expansion and those obtained after
the elevation of the flaps were determined. In addition,
skin specimens were collected from the study and control
groups following the completion of the expansions. The
specimens were stained with hematoxylin and eosin and
were examined. Radiological examinations were per-
formed to determine the apparatus function and its place-
ment (figure 5).
Results
None of the rabbits died during the experiments. Vera-
pamil injections were well tolerated by the rabbits and it
did not cause any systemic changes or systemic or local
intoxication in the rabbits. However, in the control group,
one rabbit with an expander of 200 cc and one rabbit with
an expander of 300 cc experienced exposition of their
expanders on day 18 and 15 respectively (figure 6). No
infection was detected during the procedures of expan-
sion. However, one rabbit was observed to have immobil-
ity in his hindquarters. This may have been due to
compression on the nerves.
Details of the expansions are shown in Table 1,2,3. The
expansion was completed earlier in all sizes of expanders
in the study group than in the control group. The extents
(ABs and XYs) in all verapamil groups were longer than
those in the control groups. After the expansion was com-
pleted, the expanders were removed and superior pedicled
expanded flaps 50 × 30 mm in size were harvested. The
sizes of the flaps measured after the application of an
equal pressure on the tips of the flaps are presented in
Table 4. The retraction ratios were lower in the study
group than in the control group.
Schematic view of the application of 2.46 Newton force to the tip of flaps with pulleys Figure 4
Schematic view of the application of 2.46 Newton force to the tip of flaps with pulleys.World Journal of Surgical Oncology 2003, 1 http://www.wjso.com/content/1/1/19
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The microscopic examination of the specimens taken
from each flap revealed that in the study group there was
no thickening in the epithelial tissue, the capsule around
the expander was thinner, the amount of collagen was less
and that cellularity was less and scattered (Figure 7 and 8).
Discussion
Tissue expansion is a widely used technique in surgical
oncology. Many reports have been published in the liter-
ature about reconstruction of the breast, head and neck,
face, abdominal wall and trunk with tissue expanders after
X-Ray of the apparatus Figure 5
X-Ray of the apparatus.
Table 4: Rate of retractions of the flaps in each group after elevation.
Group Expander volume Retraction of AB length Retraction of XY length
Control 100 cc 13% 13.30%
Verapamil 100 cc 8% 8.33%
Control 200 cc 18% 20%
Verapamil 200 cc 11% 15%
Control 300 cc 22% 33%
Verapamil 300 cc 13% 20%
There were two rabbits in each group, two rabbits were excluded: one rabbit in control group of the 200 cc expander, one rabbit in control group 
of 300 cc expander.World Journal of Surgical Oncology 2003, 1 http://www.wjso.com/content/1/1/19
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cancer treatment [7–10]. Neumann first reported the
concept of tissue expansion in 1957 [11]. He described
advantages of this technique as: high quality of tissue
match, avoidance of the need for a donor site, and reduc-
tion in the number of procedures necessary for reconstruc-
tion. In 1976, Radovan used tissue expanders for
reconstruction of the breast after mastectomy [12].
Subsequently, the use of tissue expansion has been popu-
larized among plastic surgeons and has become the treat-
ment of choice for many congenital and acquired defects
in children and adults [13–16].
Tissue expansion has two disadvantages; one it is time-
consuming and second it causes complications. Exposi-
tion of the expanders is frequently encountered [17,18].
In practice, the most frequently encountered
complication is capsule formation around the expanders.
This capsule not only causes difficulties in the procedure
of expansion but also decreases the size of flaps obtained
Table 1: Details of expansions in subgroup I (100 ml expanders group)
D e t a i l s g r o u p D 0D 3D 6D 9D 1 2 D 1 5 D 1 8
P r e s s u r e  ( m m  H g ) 0581 0 2 0 2 7 3 0
Inflated volume 
(percent)
Saline 0 15 31 45 60 81 100
Verapamil 0 21 47.5 74.5 103.5
AB length (mm) Saline 50 52 55.5 58 58 59.5 60.5
Verapamil 50 53 58.5 64.5 66.5
XY length (mm) Saline 30 32.5 34.5 37 37.5 37.5 38
V e r a p a m i l 3 03 54 14 2 . 5 4 6
D-days.
Table 2: Details of expansions in subgroup II: 200 ml expanders group
D e t a i l s g r o u p D 0D 3D 6D 9D 1 2 D 1 5 D 1 8
P r e s s u r e  ( m m  H g ) 03683 0 3 2 3 9
Inflated volume 
(percent)
Saline 0 15.5 31 45.5 62 80 99
Verapamil 0 22 42 65 89 106.5
A B  l e n g t h  ( m m )s a l i n e 5 0 5 2 . 55 5 5 9 . 56 2 . 56 6 6 7
v e r a p a m i l 5 05 4 . 5 6 16 76 97 5
XY length (mm) saline 40 41.5 44.5 48 49.5 51 53
v e r a p a m i l 4 04 75 35 75 96 1 . 5
There were two rabbits in each group at the beginning of the experiment but one rabbit in saline group was excluded in day 18. D-days
Table 3: Details of expansions in subgroup III: 300 ml expanders group
D e t a i l s g r o u p D 0D 3D 6D 9D 1 2 D 1 5 D 1 8 D 0
P r e s s u r e  ( m m  H g ) 0 8 1 01 82 22 53 84 5
Inflated volume 
(percent)
saline 0 15 29 44 60 77 87 100
Inflated volume 
(percent)
verapamil 0 18 38 59 78 95 108
A B  l e n g t h  ( m m ) s a l i n e 7 07 3 . 5 7 78 0 . 5 8 48 89 09 4
verapamil 70 77.5 82.5 89.5 103 106 108
X Y  l e n g t h  ( m m ) s a l i n e 5 05 25 45 65 96 06 26 5
v e r a p a m i l 5 05 8 . 5 6 3 . 5 6 57 07 37 6
There were two rabbits in each group but one rabbit in saline group was excluded in day 15. D-daysWorld Journal of Surgical Oncology 2003, 1 http://www.wjso.com/content/1/1/19
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after the expansion. Scar formation around the capsule
may result in reduced skin elasticity and impeded flap
movement, and expanded skin has a tendency to postop-
erative retraction [19]. Tension wounds have been shown
to demonstrate increased tensile strength as a result of
enhanced collagen alignment [20]. The response of the
collagen to the expansion has been studied in detail by
Timmenga [21]. Accelerated organization of the wound
collagen associated with increased tensile strength can be
considered as early maturation. The use of drugs affecting
collagen synthesis and cross linkage, both in the capsule
and in the surrounding dermis, might be of some value in
decreasing mechanical resistance of expanded tissues,
while administration of topical vasodilator drugs might
increase the filling safety margin, thus reducing the risk of
ischemia during the expansion [22]. Verapamil is found
to be effective on anti-intimal hyperplasia in a number of
animal models and decreased the myofibroblast cell pro-
liferation in the intima [23]. Verapamil is widely used top-
ically in the treatment of Peyronie's disease and keloid
because of its effects on the collagen metabolism [24–27].
Calcium antagonists increase the extra-cellular matrix col-
lagenase activity as well as decreasing the collagen, and
fibronectin synthesis and secretion, altering fibroblastic
metabolism. Lee et al, speculated that membrane calcium
channel blockers could potentially trigger extracellular
matrix degradation in dermal scars, resulting in scar vol-
ume reduction [28].
Timmenga et al concluded in their study that an expander
placed between the skin and panniculus carnossus in the
rabbit causes considerable skin stretch and affects cutane-
ous blood supply and therefore that it can be improved
for tissue expansion in humans [21]. To date, investiga-
tors have used low volume expanders (30–100 cc), while
we preferred high volume expanders, which allowed us to
evaluate frequently encountered complications in tissue
expansion. In the control group in which we used the
expanders of 200 cc and 300 cc, two expanders were
exposed. We hypothesized that the exposition might be
Complication in Group III: Exposed tissue expander Figure 6
Complication in Group III: Exposed tissue expander.
Photomicrograph of the subcutaneous tissue from verapamil  group showing lesser and scattered cellularity on the subcu- taneous tissue Figure 7
Photomicrograph of the subcutaneous tissue from verapamil 
group showing lesser and scattered cellularity on the subcu-
taneous tissue. There are no inflammatory cells. (Hematoxy-
lin eosin staining × 100 magnification)
Photomicrograph of the subcutaneous tissue from control  group showing some inflammatory cells and slightly thick- ened epidermis with 4 to 10 mitoses Figure 8
Photomicrograph of the subcutaneous tissue from control 
group showing some inflammatory cells and slightly thick-
ened epidermis with 4 to 10 mitoses. More cellularity was 
seen than the verapamil group. (Hematoxylin eosin staining × 
40 magnification)World Journal of Surgical Oncology 2003, 1 http://www.wjso.com/content/1/1/19
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associated with the pressure to which the skin is exposed
and we concluded that verapamil caused relaxation in the
tissues around the expander, which provided a safer
expansion. Moreover, verapamil allowed the use of high
volume expanders in the rabbits. There have been a
number of studies on blood circulation to the tissues
where expanders are placed [28], formation of the
capsule, tolerance of the tissues, histomorphological
changes [29] and the complications [18] since 1976.
However, there have been only a few studies on the
increased efficiency of the expanders. Brobmann and
Huber thoroughly investigated the relation between the
shape of the expanders and the outcome [30]. Their
results showed that less time, pressure, and volume are
needed in a larger implant to gain the same surface area as
would be attained in several smaller implants. Lee et al
investigated effects of chemical substances on the effi-
ciency in 1985 [31] using papaverine and cytochalasine
D. Other compounds like teophiline [32], dimethyl sul-
foxide (DMSO) [33,34] and papaverine too have been
used in humans intraoperatively [35]. The agents used to
increase the efficiency of the expansion so far, especially
cytochalasine D, have been reported to have toxic effects
[31]. Lee in his study explained the effects of anti-contrac-
tile agents and noted that contractile fibroblasts appeared
after application of tension on the dermis for only four
days [36]. If the contractile actions of these cells can be
diminished, then presumably the dermis will be more eas-
ily stretched and epidermal proliferation will maintain an
adequate surface layer over the expanding dermis.
We made use of an ordinary catheter and invented an
apparatus to administer verapamil. We also demonstrated
on radiological examination that the apparatus func-
tioned well. The mean intra-expander pressure was equal
in the study and control groups. However, the tissue
expansion was greater in the study group. It may be that
verapamil, a muscle relaxant, may have prevented the
resistance against the expansion.
As mentioned above, we measured the distances between
the spots on the skin made with crystal violet, which is a
standard method used to evaluate the expansion.
However, there is no formula to determine efficiency of
expanders precisely. The efficiency depends on the
volume and the location of expanders and etiological fac-
tors, and it is claimed that an expansion of 30% can be
achieved [37]. In this study, we obtained an expansion
ranging from 21% to 34% in the control group and an
expansion ranging from 33% to 54% in the study group.
Although there has been no study investigating the retrac-
tion ratio in the literature, it has been reported that the
body responds quickly to the removal of the mechanical
effect exerted by the expander. In practice, it is commonly
encountered that a little retraction of the flaps is possible
after the expander is extracted and until the flaps are trans-
ferred into the recipient area. In this study, the retraction
ratios determined after the elevation of the flaps were
lower in the rabbits administered verapamil.
Conclusions
The topical usage of verapamil increases the efficiency of
expanders, frequently used in reconstructive surgery, and
decreases the complications. Thus, it provides less
retracted flaps in larger volumes and in a very short time.
Verapamil is safer and more potent than the other anti-
contractile agents, which increases its use in practice.
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